NCT07190755Recruiting
Impact of Patient-Reported Outcomes for Symptom Monitoring in Patients Followed for Head and Neck Squamous Cell Carcinoma (HNSCC)
Impact of Patient-Reported Outcomes for Symptom Monitoring in Patients Followed for Curative Treatment of Head and Neck Squamous Cell Carcinoma (HNSCC) With Radiotherapy or Chemoradiotherapy
Source: ClinicalTrials.gov · Last updated 30 Dec 2025
Brief summary (registry, in English)
The use of digital strategies to systematically monitor patients' symptoms in clinical settings allows problems to be detected at an early stage before they worsen or lead to complications. In this study, the hypothesis is that the proportion of patients with a weight loss of at least 5% between before radiotherapy/radiochemotherapy and 3 months after treatment would be lower with optimised care thanks to remote monitoring using a medical telemonitoring solution in oncology.
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 192 (estimated)
- First submitted
- 17 Sept 2025
- Start date
- 15 Oct 2025
- Primary completion date
- 1 Jun 2030
- Lead sponsor
- Centre Henri Becquerel
- Diseases
- Head and neck cancer
- NCT number
- NCT07190755
What you commit to
- Study type: Interventional
- Planned participants: 192
- From 15 Oct 2025 to the primary completion date, 1 Jun 2030
- 2 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- History of other neoplastic disease less than 2 years ago or progressive disease,
- History of ENT radiotherapy,
Other
- Pregnant or breastfeeding women,
- Protected adults (under guardianship, curatorship or judicial protection),
- Patients participating in a therapeutic study,
- Patients unable to understand the study for any reason or to comply with the constraints of the trial (language, psychological or geographical issues, etc.), patients with blindness preventing the use of the medical telemonitoring solution in oncology.
Who the study is looking for
- Patient aged over 18 and under 75 years WHO score \< 2,
- Treated for localised heand and neck cancer of the squamous cell carcinoma type for which curative treatment has been chosen and receiving radiotherapy or radio-chemotherapy exclusively or as an adjuvant with the aim of cure
- Having signed the informed consent form,
- Affiliated with or beneficiary of a social protection scheme,
- Access to a smartphone or the internet,
Age in the registry: 18 years to 75 years · Sex: All · Does not accept healthy volunteers
Sites (2)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Centre Henri Becquerel Coordinator of this site? Confirm its status | Rouen | France | Recruiting |
| Institut de Cancérologie de Lorraine Coordinator of this site? Confirm its status | Vandœuvre-lès-Nancy | France | Not yet recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.